Details for New Drug Application (NDA): 018977

✉ Email this page to a colleague

NDA 018977 describes TRI-NORINYL 28-DAY, which is a drug marketed by Dr Reddys Labs Sa and is included in one NDA. It is available from one supplier. Additional details are available on the TRI-NORINYL 28-DAY profile page.

The generic ingredient in TRI-NORINYL 28-DAY is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for 018977

Tradename:	TRI-NORINYL 28-DAY
Applicant:	Dr Reddys Labs Sa
Ingredient:	ethinyl estradiol; norethindrone
Patents:	0

Suppliers and Packaging for NDA: 018977

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TRI-NORINYL 21-DAY	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018977	NDA AUTHORIZED GENERIC	Mayne Pharma Inc.	51862-471	51862-471-06	6 BLISTER PACK in 1 CARTON (51862-471-06) / 1 KIT in 1 BLISTER PACK (51862-471-01)
TRI-NORINYL 28-DAY	ethinyl estradiol; norethindrone	TABLET;ORAL-28	018977	NDA AUTHORIZED GENERIC	Mayne Pharma Inc.	51862-471	51862-471-06	6 BLISTER PACK in 1 CARTON (51862-471-06) / 1 KIT in 1 BLISTER PACK (51862-471-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL-21			Strength	0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
Approval Date:	Apr 13, 1984	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL-28			Strength	0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG
Approval Date:	Apr 13, 1984	TE:	AB	RLD:	Yes

Expired US Patents for NDA 018977

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dr Reddys Labs Sa	TRI-NORINYL 21-DAY	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018977-001	Apr 13, 1984	4,390,531	⤷ Subscribe
Dr Reddys Labs Sa	TRI-NORINYL 28-DAY	ethinyl estradiol; norethindrone	TABLET;ORAL-28	018977-002	Apr 13, 1984	4,390,531	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.